What is Poly Medicure Ltd (POLYMED) share price today?

Poly Medicure Ltd (POLYMED) is listed on the NSE. Visit VestAI at https://www.vestai.io/stocks/POLYMED for the latest live price, technical analysis, and AI-powered insights.

How to analyse POLYMED stock?

VestAI provides comprehensive POLYMED stock analysis including RSI, MACD, Bollinger Bands, SMA trend, ROCE, debt-to-equity ratio, and smart money holdings by superstar investors.

What sector is Poly Medicure Ltd in?

Poly Medicure Ltd (POLYMED) is in the Healthcare sector, Medical Equipment & Supplies industry on the NSE.

Poly Medicure Ltd

Name: Poly Medicure Ltd (POLYMED) Financial Metrics
Creator: VestAI
License: https://www.vestai.io/terms

POLYMED

NSE· Healthcare

₹1,647.70

-33.00 (-1.96%)

52W Low · ₹1,195.6052W High · ₹2,144.90

Mid Range

Market Cap

₹14408.06L Cr

Volume

42.3K

Prev Close

₹1,664.00

ISIN

INE205C01021

Orion Score

Fundamentals-based quality & risk · not a recommendation

68/100

Quality

Poly Medicure Ltd scores 68/100 (Quality) on the Orion Score — moderate business quality (69), strong growth (82), strong balance-sheet safety (83) and rich valuation (30). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality

Growth

Safety

Value

Full Orion analysis

Risk checks

Profit converts to cash (CFO 0.9× PAT)
Low debt, comfortable interest cover
No distress, manipulation or dilution flags

Forensic accounting

Piotroski F 3/9Altman Z Safe(9.07)Beneish M Elevated(-2.15)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

62/100

Neutral

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION

Low Debt

D/E 0.11x — lean balance sheet

QUALITY

Low Quality

ROCE 9.8% — poor capital efficiency

MOMENTUM

Neutral

RSI 54.6 — consolidating

Price Chart

SMA 20

SMA 50

SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio: 44.65
ROCE: 9.78%
ROE (1Y): 10.85%
D/E Ratio: 0.11x
OPM: 13.50%
TTM EPS: ₹31.80
Dividend Yield: 25.00%
Qtrly Sales: ₹534.51 Cr
Qtrly Profit: ₹65.04 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit

Quarter	Revenue	Net Profit	OPM	EPS
Q4 2026	₹534.51	₹65.04	13.5%	₹6.53
Q3 2026	₹493.66	₹70.93	-15.1%	₹6.99
Q2 2026	₹443.88	₹91.83	20.2%	₹9.06
Q1 2026	₹403.21	₹93.08	20.6%	₹9.17
Q4 2025	₹440.83	₹91.83	22.3%	₹8.92

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit

Year	Revenue	Net Profit	EBITDA	OPM
FY 2026	₹1,875.26	₹331.29	₹561.28	17.4%
FY 2025	₹1,669.83	₹338.56	₹547.69	22.2%
FY 2024	₹1,365.69	₹258.26	₹418.89	22.2%
FY 2023	₹1,108.66	₹179.28	₹303.2	19.6%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

Company	Mkt Cap	P/E	ROCE	ROE	D/E	OPM
POLYMED ★	₹14,408 Cr	44.65	9.78%	10.85%	0.11x	13.50%
SUNPHARMASun Pharmaceutical Industries	₹4,27,609 Cr	37.32	15.73%	14.72%	0.06x	18.90%
MAXHEALTHMax Healthcare Institute	₹95,110 Cr	66.21	11.94%	14.33%	0.32x	22.56%
AUROPHARMAAurobindo Pharma Limited	₹88,148 Cr	25.39	12.55%	9.93%	0.21x	15.11%
ASTERDMAster DM Quality	₹68,390 Cr	104.34	8.93%	10.07%	0.46x	13.98%
ABBOTINDIAAbbott India Limited	₹59,509 Cr	38.28	36.31%	34.46%	0.04x	27.01%

Balance Sheet

All values in ₹ Crores

Metric	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	₹3,192.45	₹1,858.67	₹1,577.21	₹1,376.83
Equity	₹2,765.66	₹1,470.05	₹1,241.63	₹1,087.48
Total Debt	₹180.25	₹173.9	₹149.02	₹126.71
Cash	₹8.7	₹12.05	₹7.06	₹7.76
Net Debt	₹168.95	₹157.91	₹139.37	₹117.52
Working Capital	₹1,546.83	₹490.39	₹513.39	₹556.76

Shareholding Pattern

Q1 FY2027

Promoter

67.91%

FII

11.97%

DII

9.8%

Public

10.32%

Quarter-over-Quarter Trend

Quarter	Promoter	FII	DII	Public
Q1 FY2027	67.91% ↑	11.97% ↑	9.8% ↓	10.32% ↓
Q3 FY2026	62.42%	9.41% ↓	13.84% ↑	14.34% ↑
Q2 FY2026	62.42% ↓	9.77% ↓	13.53% ↑	14.28% ↓
Q1 FY2026	62.44%	11.41% ↓	11.72% ↓	14.43% ↑
Q4 FY2025	62.44%	11.46% ↓	11.96% ↑	14.13% ↑
Q3 FY2025	62.44% ↓	12.33% ↑	11.66% ↓	13.57% ↑
Q2 FY2025	62.56% ↓	11.88% ↑	12.33% ↑	13.23% ↓
Q1 FY2025	66.02%	9.91%	9.34%	14.72%

Corporate Actions

No recent corporate actions

Funds Holding This Stock

57 mutual fund schemes

qsif Equity Ex Top 100 Long Short Fund Direct Plan GrowthQSIF

2.24%

₹0 Cr

SBI Healthcare Opportunities Fund Direct Plan GrowthSBI

1.89%

₹86 Cr

Quant Small Cap Fund Direct Plan GrowthESCORTS

1.85%

₹588 Cr

Invesco India Largecap Fund Direct GrowthINVESCO

1.34%

₹25 Cr

DSP Nifty Smallcap250 Quality 50 Index Fund Direct GrowthDSP

1.30%

₹4 Cr

SBI MNC Direct Plan GrowthSBI

1.25%

₹76 Cr

qsif Hybrid Long Short Fund Direct Plan GrowthQSIF

1.11%

₹0 Cr

WhiteOak Capital Quality Equity Fund Direct GrowthWHITEOAK_CAPITAL

1.05%

₹6 Cr

Baroda BNP Paribas Health and Wellness Fund Direct GrowthBARODABNPPARIBASMUTUALFUND_MF

0.95%

₹5 Cr

WhiteOak Capital Pharma and Healthcare Fund Direct GrowthWHITEOAK_CAPITAL

0.90%

₹6 Cr

Analyse POLYMED with Orion AI

Ask: "Is Poly Medicure Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Poly Medicure Ltd (POLYMED) Stock

Poly Medicure Ltd is listed on the NSE under the Healthcare sector, Medical Equipment & Supplies industry. ISIN: INE205C01021. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.